Antidepressant activity and mania associated with risperidone treatment of schizoaffective disorder

The Lancet

Volumn 344, Issue 8921, 1994, Pages 554-555

  Dwight, MeganM ^a   Keck Jr , PaulE ^a   Stanton, SeanP ^a   Strakowski, StephenM ^a   McElroy, SusanL ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; LITHIUM; RISPERIDONE; VALPROIC ACID;

ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; HUMAN; LETTER; MANIA; PRIORITY JOURNAL; SCHIZOAFFECTIVE PSYCHOSIS;

EID: 0028142093     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(94)91952-6     Document Type: Letter

References (4)

1. Pharmacologic treatment of schizoaffective disorder
2. Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia
3. Risperidone in the treatment of disorders with a combined psychotic and depressive syndrome—a functional approach
4. Risperidone